Abstract:Breast cancer is the most frequently diagnosed cancer among women, and the circulating tumor cell (CTC)-meditated distant metastasis is the leading cause of death. Thus, the detection of CTCs is of great importance for the early diagnosis of breast cancer and the prevention of metastasis. In this study, using human breast carcinoma BT474 cells as the model CTCs, a powerful assay platform is demonstrated by fluorescence spectrometry for the highly sensitive CTC detection by combining the dual-recognizing elements receptor-binding antibody and aptamer-mediated separation with double rolling circle amplification reactions (d-RCA, including RCA1 and RCA2). The aptamer-inserted RCA1 product (RCA1-p) exhibits the considerably improved affinity towards target cells originating from the multivalent binding effect. The immunomagnetic separation removes nontarget cells coexisting in complex biological milieu, while the centrifugal separation of cells/DNAs mixture eliminates the excess probes, thereby circumventing the unwanted interferences. The fluorescence spectrometric results show that a 34-fold enhanced fluorescence signal is achieved upon BT474 cells, and the target cells can be quantitatively detected down to 9 cells/200 μL with the linear range of five orders of magnitude, indicating a significantly enhanced detection performance. Even if BT474 cells are spiked in the fresh whole blood, no obvious fluctuation in the fluorescence signal is detected, demonstrating that the newly developed d-RCA assay system is suitable for screening CTCs in complex environments and is expected to be a promising tool for estimating distant metastasis and predicting the recurrence of tumors.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssensors.0c01082?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssensors.0c01082</a>.Materials and reagents, comparison of detection capability between aptamer-mediated d-RCA and previous systems, nPAGE analysis to evaluate the RCA2-p productivity, optimization of experimental conditions, laser confocal microscope images, flow cytometry analysis to evaluate the signal amplification of the d-RCA system, specific recognition of the d-RCA system, and flow analysis based on a simplified detection scheme (<a class="ext-link" href="/doi/suppl/10.1021/acssensors.0c01082/suppl_file/se0c01082_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Selection of DNA aptamer recognizing CD44 for high-efficiency capture of circulating tumor cells

Rapid Identification Of Specific Dna Aptamers Precisely Targeting Cd33 Positive Leukemia Cells Through A Paired Cell-Based Approach

A rapid and simple method for efficient capture and accurate discrimination of circulating tumor cells using aptamer conjugated magnetic beads and surface-enhanced Raman scattering imaging

Combination of Immunomagnetic Separation with Aptamer-Mediated Double Rolling Circle Amplification for Highly Sensitive Circulating Tumor Cell Detection

Selective Capture and Quick Detection of Targeting Cells with SERS-Coding Microsphere Suspension Chip.

Accurate Isolation of Circulating Tumor Cells via a Heterovalent DNA Framework Recognition Element-Functionalized Microfluidic Chip

Bioinspired DNA Nanointerface with Anisotropic Aptamers for Accurate Capture of Circulating Tumor Cells

Efficient Detection of Single Circulating Tumor Cell in Blood Using Raman Mapping Based on Aptamer-SERS Bio-Probe Coupled with Micropore Membrane Filtration.

Magnetic Pollen-Like Silica Nanoparticles for Efficient Capture of Circulating Tumor Cells

Fabrication of a Polyvalent Aptamer Network on an Electrode Surface for Capture and Analysis of Circulating Tumor Cells

A Dual-Recognition-controlled Electrochemical Biosensor for Accurate and Sensitive Detection of Specific Circulating Tumor Cells.

Magnetic bead-based electrochemical and colorimetric assays of circulating tumor cells with boronic acid derivatives as the recognition elements and signal probes

Direct Analysis of Rare Circulating Tumor Cells in Whole Blood Based on Their Controlled Capture and Release on Electrode Surface.

Long cruising aptamer-albumin nanobots intelligently capture and restrain circulating tumor cells

SERS and fluorescence detection of circulating tumor cells (CTCs) with specific capture-release mode based on multifunctional gold nanomaterials and dual-selective recognition

Dual targeting negative enrichment strategy for highly sensitive and purity detection of CTCs

Dual-Aptamer-Targeted Immunomagnetic Nanoparticles to Accurately Explore the Correlations between Circulating Tumor Cells and Gastric Cancer

Genetically Engineered Cell Membrane‐Coated Magnetic Nanoparticles for High‐Performance Isolation of Circulating Tumor Cells

A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells

Ultrasensitive Capture, Detection, and Release of Circulating Tumor Cells Using a Nanochannel-Ion Channel Hybrid Coupled with Electrochemical Detection Technique.

General Applicable Circulating Tumor Cell Enrichment and Identification Through the Membrane Glycoprotein-targeted Strategy Combining Magnetic Isolation and Biological Orthogonality Labeling